查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1736637

全球心臟影像軟體市場規模（依顯像模式、最終用戶、應用、地區、預測）- 2020 年

Global Cardiac Imaging Software Market Size By Imaging Modalities, By End-User, By Application, By Geographic Scope And Forecast
出版日期: | 出版商: Verified Market Research | 英文 202 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

心臟影像軟體市場規模與預測

2024 年心臟影像軟體市場規模價值為 5.0413 億美元，預計到 2032 年將達到 9.0681 億美元，在 2026-2032 年預測期內的複合年成長率為 8.40%。

由於影像設備技術的進步、人口老化以及心血管手術的增加，全球心臟影像軟體市場預計將持續成長。心臟影像軟體市場報告對市場進行了全面的評估，包括關鍵細分市場、趨勢、市場促進因素、限制因素、競爭格局以及影響市場的關鍵因素。

全球心臟影像軟體市場概況

心血管疾病 (CVD) 盛行率的上升是全球住院的主要原因之一。據世界衛生組織稱，CVD 是全球最大的死亡原因，估計每年奪走 1800 萬人的生命。由於心血管疾病的發生率不斷上升，對使用 MRI、 電腦斷層掃描、血管造影術、放射化學物質和其他同步輻射來識別心臟相關問題的心臟影像軟體的需求也日益成長。此外，老年人口的成長、技術進步、CT、PET 等心臟影像方式的使用增加、心血管疾病的根本原因增加以及市場參與企業針對這些因素制定的發展計劃等因素預計將使全球心臟影像軟體市場受益。

高成本主要是因為現代技術成本高昂、診斷測試的大量使用以及藥理學和醫學治療。在美國，診斷影像費用每年超過 1000 億美元。心血管影像 (CVI) 佔總診斷影像負擔的 29%，佔全球每年進行的數十億次診斷影像測試的至少三分之一。此外，這是由於專有軟體產品的結合以及與其他軟體和硬體提供者的互通性。而且，各個供應商之間並不統一。這使得進行多中心、基於人群的研究變得困難，因為數據可能來自不同供應商生產的設備。因此，預計全球心臟影像軟體市場的成長將放緩。

目錄

第1章 引言

  • 市場概覽
  • 研究範圍
  • 先決條件

第2章執行摘要

第3章：已驗證的市場研究調查方法

  • 資料探勘
  • 驗證
  • 第一手資料
  • 資料來源列表

第4章 市場概述

  • 概述
  • 市場動態
    • 驅動程式
    • 限制因素
    • 機會
  • 波特五力模型
  • 價值鏈分析

第5章。心臟影像軟體市場（以顯像模式）

  • 概述
  • 電腦斷層掃描
  • 磁振造影
  • 超音波影像
  • X光影像
  • 多模態

第6章心臟影像軟體市場（按最終用戶）

  • 概述
  • 醫院和診所
  • 診斷中心
  • 其他

第7章心臟影像軟體市場（按應用）

  • 概述
  • 影像學診斷
  • 影像導引治療
  • 病患監測

第8章心臟影像軟體市場（按地區）

  • 概述
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 其他歐洲國家
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 其他亞太地區
  • 世界其他地區
    • 拉丁美洲
    • 中東和非洲

第9章 競爭態勢

  • 概述
  • 各公司市場排名
  • 主要發展策略

第10章 公司簡介

  • Shimadzu Corporation
  • Koninklijke Philips NV
  • Siemens AG
  • Canon Inc.
  • Agfa-Gevaert Group
  • General Electric
  • Circle Cardiovascular
  • Fujifilm Holdings Corporation
  • Symphony Innovations, LLC
  • Pie Medical Imaging

第11章 重大進展

  • 產品發布/開發
  • 合併與收購
  • 業務擴展
  • 夥伴關係與合作

第12章 附錄

  • 相關調查
簡介目錄
Product Code: 38108

Cardiac Imaging Software Market Size And Forecast

Cardiac Imaging Software Market size was valued at USD 504.13 Million in 2024 and is projected to reach USD 906.81 Million by 2032, growing at a CAGR of 8.40% from 2026 to 2032.

The global Cardiac Imaging Software Market is predicted to develop due to technical improvements in imaging equipment, an older population, and an increase in heart procedures. The Global Cardiac Imaging Software Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

Cardiac Imaging Software Market Size And Forecast

Cardiac Imaging Software Market size was valued at USD 504.13 Million in 2024 and is projected to reach USD 906.81 Million by 2032, growing at a CAGR of 8.40% from 2026 to 2032.

The global Cardiac Imaging Software Market is predicted to develop due to technical improvements in imaging equipment, an older population, and an increase in heart procedures. The Global Cardiac Imaging Software Market report provides a holistic evaluation of the market. The report offers a comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

Global Cardiac Imaging Software Market Overview

The rising prevalence of cardiovascular diseases (CVD) is one of the primary reasons for hospitalization worldwide. According to WHO, CVDs are the leading cause of mortality worldwide, claiming an estimated 18 million lives each year. As a result of the increased frequency of cardiovascular disorders, there is a greater need for cardiac imaging software to identify heart-related issues using MRI, CT scan, angiography, radioactive chemicals, and other types of radiant light. Furthermore, factors such as an increase in the older population, technological improvements, and increased use of cardiac imaging modalities such as CT, PET, and others, a Rise in underlying causes of cardiovascular disease, and market participants' development plans of these factors are projected to benefit the worldwide Cardiac Imaging Software Market.

The high cost is mostly due to the high expense of contemporary technology, the extensive use of diagnostic tests, and pharmacological and medical therapies. In the United States, imaging expenses surpass USD 100 billion each year. Cardiovascular imaging (CVI) accounts for 29 percent of the total imaging burden and at least one-third of the several billion medical imaging exams conducted worldwide each year. Furthermore, this was ascribed in part to proprietary software products and their built-in interoperability with other software and hardware providers. Furthermore, there is a lack of uniformity across providers. This makes multi-site, population-based research challenging to conduct, as data may be acquired from gear produced by various suppliers. This is projected to slow the global Cardiac Imaging Software Market's growth.

Global Cardiac Imaging Software Market Segmentation Analysis

The Global Cardiac Imaging Software Market is Segmented on the basis of Imaging Modalities, End-User, Application, and Geography.

Cardiac Imaging Software Market, By Imaging Modalities

  • Computed Tomography
  • Magnetic Resonance
  • Ultrasound Imaging
  • X-Ray Imaging
  • Combined Modalities

Based on Imaging Modalities, the market is segmented into Computed Tomography, Magnetic Resonance, Ultrasound Imaging, X-Ray Imaging, and Combined Modalities. The computed tomography sector is predicted to increase at a healthy rate over the projection period because it is more efficient than conventional X-rays at delivering doses of cancer-damaging radiation.

Cardiac Imaging Software Market, By End-User

  • Hospital & Clinics
  • Diagnostic Centers
  • Others

Based on End-User, the market is segmented into Hospitals & Clinics, Diagnostic Centers, and Others. The market has seen a dramatic surge in the number of patients suffering from cardiovascular illnesses such as coronary heart disease, heart attacks, strokes, congenital heart disease, and others during the previous few years. The number of hospitals worldwide is steadily rising as the number of patients increases. By end-user, hospitals and clinics dominate the worldwide Cardiac Imaging Software Market. This share is mostly due to an increase in the number of individuals being monitored for a heart condition.

Cardiac Imaging Software Market, By Application

  • Diagnostic Imaging
  • Image Guided Treatment
  • Patient Monitoring

Based on Application, the market is segmented into Diagnostic Imaging, Image Guided, and Patient Monitoring.

Cardiac Imaging Software Market, By Geography

  • North America
  • Europe
  • Asia Pacific
  • Rest of the world
  • On the basis of Geography, the Global Cardiac Imaging Software Market is classified into North America, Europe, Asia Pacific, and the Rest of the world. North America Americas accounted for the majority of the global market because of the high prevalence of cardiovascular diseases, technological advancements, high disposable income, a growing older population, and a favorable regulatory environment. The rise in the frequency of heart diseases is linked to North America's dominance.

Key Players

The "Global Cardiac Imaging Software Market" study report will provide valuable insight with an emphasis on the global market including some of the major players such as Shimadzu Corporation, Koninklijke Philips NV, Siemens AG, Canon Inc., Agfa-Gevaert Group, General Electric, Circle Cardiovascular, Fujifilm Holdings Corporation, Symphony Innovation, LLC, and Pie Medical Imaging.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share and market ranking analysis of the above-mentioned players globally.

Key Developments

  • In June 2021, Circle Cardiovascular Imaging Inc. (Canada) formed an alliance with DiA Imaging Analysis (Israel). This collaboration will provide clients with all-in-one complete Ai-based cardiovascular imaging solutions, as well as new potential in multi-modality imaging solutions for physicians, patients, and hospitals globally. Circle's cardiac imaging offering will be strengthened by DiA's FDA-cleared and CE-marked LVivo Toolbox, a series of breakthrough AI-based cardiac ultrasound products.
  • In June 2021, GE Healthcare (US) partnered with the American College of Cardiology (US) to develop artificial intelligence and digital health technology in cardiology.
  • In March 2021, TeraRecon, one of the top healthcare imaging AI technology businesses, has been acquired by Symphony Innovation, LLC (US). Symphony AI Group has begun its new range of healthcare AI solutions centered on medical imaging with this purchase.

TABLE OF CONTENTS

1 INTRODUCTION OF GLOBAL CARDIAC IMAGING SOFTWARE MARKET

  • 1.1 Overview of the Market
  • 1.2 Scope of Report
  • 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

  • 3.1 Data Mining
  • 3.2 Validation
  • 3.3 Primary Interviews
  • 3.4 List of Data Sources

4 GLOBAL CARDIAC IMAGING SOFTWARE MARKET OUTLOOK

  • 4.1 Overview
  • 4.2 Market Dynamics
    • 4.2.1 Drivers
    • 4.2.2 Restraints
    • 4.2.3 Opportunities
  • 4.3 Porters Five Force Model
  • 4.4 Value Chain Analysis

5 GLOBAL CARDIAC IMAGING SOFTWARE MARKET, BY IMAGING MODALITY

  • 5.1 Overview
  • 5.2 Computed Tomography
  • 5.3 Magnetic Resonance
  • 5.4 Ultrasound Imaging
  • 5.5 X-Ray Imaging
  • 5.6 Combined Modalities

6 GLOBAL CARDIAC IMAGING SOFTWARE MARKET, BY END-USER

  • 6.1 Overview
  • 6.2 Hospitals & Clinics
  • 6.3 Diagnostics Centers
  • 6.4 Others

7 GLOBAL CARDIAC IMAGING SOFTWARE MARKET, BY APPLICATION

  • 7.1 Overview
  • 7.2 Diagnostic Imaging
  • 7.3 Image Guided Treatment
  • 7.4 Patient Monitoring

8 GLOBAL CARDIAC IMAGING SOFTWARE MARKET, BY GEOGRAPHY

  • 8.1 Overview
  • 8.2 North America
    • 8.2.1 U.S.
    • 8.2.2 Canada
    • 8.2.3 Mexico
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 U.K.
    • 8.3.3 France
    • 8.3.4 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 India
    • 8.4.4 Rest of Asia Pacific
  • 8.5 Rest of the World
    • 8.5.1 Latin America
    • 8.5.2 Middle East and Africa

9 GLOBAL CARDIAC IMAGING SOFTWARE MARKET COMPETITIVE LANDSCAPE

  • 9.1 Overview
  • 9.2 Company Market Ranking
  • 9.3 Key Development Strategies

10 COMPANY PROFILES

  • 10.1 Shimadzu Corporation
    • 10.1.1 Overview
    • 10.1.2 Financial Performance
    • 10.1.3 Product Outlook
    • 10.1.4 Key Developments
  • 10.2 Koninklijke Philips NV
    • 10.2.1 Overview
    • 10.2.2 Financial Performance
    • 10.2.3 Product Outlook
    • 10.2.4 Key Developments
  • 10.3 Siemens AG
    • 10.3.1 Overview
    • 10.3.2 Financial Performance
    • 10.3.3 Product Outlook
    • 10.3.4 Key Developments
  • 10.4 Canon Inc.
    • 10.4.1 Overview
    • 10.4.2 Financial Performance
    • 10.4.3 Product Outlook
    • 10.4.4 Key Developments
  • 10.5 Agfa-Gevaert Group
    • 10.5.1 Overview
    • 10.5.2 Financial Performance
    • 10.5.3 Product Outlook
    • 10.5.4 Key Developments
  • 10.6 General Electric
    • 10.6.1 Overview
    • 10.6.2 Financial Performance
    • 10.6.3 Product Outlook
    • 10.6.4 Key Developments
  • 10.7 Circle Cardiovascular
    • 10.7.1 Overview
    • 10.7.2 Financial Performance
    • 10.7.3 Product Outlook
    • 10.7.4 Key Developments
  • 10.8 Fujifilm Holdings Corporation
    • 10.8.1 Overview
    • 10.8.2 Financial Performance
    • 10.8.3 Product Outlook
    • 10.8.4 Key Developments
  • 10.9 Symphony Innovations, LLC
    • 10.9.1 Overview
    • 10.9.2 Financial Performance
    • 10.9.3 Product Outlook
    • 10.9.4 Key Developments
  • 10.10 Pie Medical Imaging
    • 10.10.1 Overview
    • 10.10.2 Financial Performance
    • 10.10.3 Product Outlook
    • 10.10.4 Key Developments

11 KEY DEVELOPMENTS

  • 11.1 Product Launches/Developments
  • 11.2 Mergers and Acquisitions
  • 11.3 Business Expansions
  • 11.4 Partnerships and Collaborations

12 Appendix

  • 12.1 Related Research